Iodixanol Nasal Solution Reduces Allergic Rhinoconjunctivitis Signs and Symptoms in Allergen BioCube®: Randomized Clinical Trial

Journal Title: Global Journal of Allergy - Year 2018, Vol 4, Issue 1

Abstract

Purpose: Allergic rhinitis (AR) affects ~20% of the population worldwide. The objectives of this study were to evaluate the safety and efficacy of iodixanol nasal solution (Nasapaque) for AR treatment, using the Allergen BioCube®, an environmental exposure unit. Iodixanol is a commonly used contrast media agent that shows efficacy on the signs and symptoms of AR.

Authors and Affiliations

pj Gomes, MB Abelson, L Stein, E Viirre, JE Villafranca, EC Lasser

Keywords

Related Articles

Polyphenols and their Mechanism of Action in Allergic Immune Response

Mini review article deals with the most studied group of chemical compounds – polyphenols – predominantly flavonoids in relation to their allergic immune response. There is clarified and discussed their mechanism of acti...

Preliminary Survey of Water Hyacinth in Lake Tana, Ethiopia

Investigation of water hyacinth was conducted from October 27, 2011 to November 3, 2011 by interdisciplinary expedition groups. A total of 24 sites were delineated using geographical positioning system (GPS) during inves...

Atopic Eczema - From Epidemiology to Therapeutic Approach

Atopic dermatitis is one of the epidemically expanding non-infectious diseases in the 21 century. It poses immense challenges to both patients and physicians. With a steady growth in its incidence and prevalence, the dis...

Anaphylaxis to the Citrus Fruit Yuzu

Introduction: We report a selective anaphylaxis to yuzu (Citrus junos). Case Presentation: A 42-year-old woman, with no atopic history, has experienced two anaphylactic reactions after consuming yuzu. Skin prick tests (...

Plastic Bronchitis: A Case Report

Plastic bronchitis is a rare disease characterized by the formation of bronchial casts that can cause partial or complete obstruction of the airway. In this case report, a patient aged four years, previously healthy, beg...

Download PDF file
  • EP ID EP533551
  • DOI 10.17352/2455-8141.000021
  • Views 56
  • Downloads 0

How To Cite

pj Gomes, MB Abelson, L Stein, E Viirre, JE Villafranca, EC Lasser (2018). Iodixanol Nasal Solution Reduces Allergic Rhinoconjunctivitis Signs and Symptoms in Allergen BioCube®: Randomized Clinical Trial. Global Journal of Allergy, 4(1), 1-8. https://europub.co.uk/articles/-A-533551